These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32905781)

  • 1. YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.
    Liu J; Gao M; Xu S; Chen Y; Wu K; Liu H; Wang J; Yang X; Wang J; Liu W; Bao X; Chen J
    Cell Rep; 2020 Sep; 32(10):108120. PubMed ID: 32905781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex.
    Du H; Zhao Y; He J; Zhang Y; Xi H; Liu M; Ma J; Wu L
    Nat Commun; 2016 Aug; 7():12626. PubMed ID: 27558897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting m
    Zhang W; Wu T; Zhang Y; Kang W; Du C; You Q; Chen X; Jiang Z
    Bioorg Med Chem; 2023 Jul; 90():117373. PubMed ID: 37329678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms Driving mRNA Degradation by m
    Lee Y; Choe J; Park OH; Kim YK
    Trends Genet; 2020 Mar; 36(3):177-188. PubMed ID: 31964509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YTHDF3 facilitates translation and decay of N
    Shi H; Wang X; Lu Z; Zhao BS; Ma H; Hsu PJ; Liu C; He C
    Cell Res; 2017 Mar; 27(3):315-328. PubMed ID: 28106072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms.
    Chen L; Gao Y; Xu S; Yuan J; Wang M; Li T; Gong J
    Front Immunol; 2023; 14():1162607. PubMed ID: 36999016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ythdf m
    Kontur C; Jeong M; Cifuentes D; Giraldez AJ
    Cell Rep; 2020 Dec; 33(13):108598. PubMed ID: 33378672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Unified Model for the Function of YTHDF Proteins in Regulating m
    Zaccara S; Jaffrey SR
    Cell; 2020 Jun; 181(7):1582-1595.e18. PubMed ID: 32492408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine-dependent regulation of messenger RNA stability.
    Wang X; Lu Z; Gomez A; Hon GC; Yue Y; Han D; Fu Y; Parisien M; Dai Q; Jia G; Ren B; Pan T; He C
    Nature; 2014 Jan; 505(7481):117-20. PubMed ID: 24284625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDF2 destabilizes m
    Heck AM; Russo J; Wilusz J; Nishimura EO; Wilusz CJ
    RNA; 2020 Jun; 26(6):739-755. PubMed ID: 32169943
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism underlying redundant functions of the YTHDF proteins.
    Zou Z; Sepich-Poore C; Zhou X; Wei J; He C
    Genome Biol; 2023 Jan; 24(1):17. PubMed ID: 36694229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
    Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J
    Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-145 Modulates
    Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
    J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
    [No Abstract]   [Full Text] [Related]  

  • 15. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency.
    Wang X; Zhao BS; Roundtree IA; Lu Z; Han D; Ma H; Weng X; Chen K; Shi H; He C
    Cell; 2015 Jun; 161(6):1388-99. PubMed ID: 26046440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.
    Mapperley C; van de Lagemaat LN; Lawson H; Tavosanis A; Paris J; Campos J; Wotherspoon D; Durko J; Sarapuu A; Choe J; Ivanova I; Krause DS; von Kriegsheim A; Much C; Morgan M; Gregory RI; Mead AJ; O'Carroll D; Kranc KR
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33156926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis.
    Li HM; Tang F; Wang LJ; Huang Q; Pan HF; Zhang TP
    Front Public Health; 2022; 10():925303. PubMed ID: 36072379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
    Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Qi M; Sun H; Guo Y; Zhou Y; Gu X; Jin J; Chen X; Wang F; Ma H; Guo X; Chen H; Shen B
    Cell Prolif; 2022 Jan; 55(1):e13164. PubMed ID: 34850470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
    Hou J; Zhang H; Liu J; Zhao Z; Wang J; Lu Z; Hu B; Zhou J; Zhao Z; Feng M; Zhang H; Shen B; Huang X; Sun B; Smyth MJ; He C; Xia Q
    Mol Cancer; 2019 Nov; 18(1):163. PubMed ID: 31735169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.